Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 12:03 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1921–1944 of 4,345 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Time Management Clear all

Conditions: Opioid Use, Auriculotherapy, Pain, Abdominal, Cancer Pain, Liver Transplant
Interventions: NSS-2 BRIDGE, Sham NSS-2 BRIDGE; Device
Lead sponsor: Jacques E. Chelly; Other
Eligibility: 18 Years and older
Enrollment: 286 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 4
States / cities: Pittsburgh, Pennsylvania

Conditions: Head and Neck Neoplasms, Mucositis
Interventions: Brilacidin, Placebo; Drug · Other
Lead sponsor: Innovation Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 61 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 16
States / cities: Gilbert, Arizona • Lakeland, Florida • Columbus, Georgia + 13 more

Conditions: Sarcoma
Interventions: Interview, Observations, Guided Activities; Behavioral
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: 7 Years to 11 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Chronic Obstructive Pulmonary Disease
Interventions: Resistance training, Aerobic training; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 46 Years and older
Enrollment: 354 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Opioid Use Disorder
Interventions: Recovery Connect; Device
Lead sponsor: Bright Therapeutics; Industry
Eligibility: 18 Years and older
Enrollment: 1,524 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 9
States / cities: Anchorage, Alaska • Wasilla, Alaska • Billings, Montana + 6 more

Conditions: Renal Replacement Therapy, Pharmacokinetics
Interventions: Cefazolin; Drug
Lead sponsor: Drexel University; Other
Eligibility: Not listed
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Pre-term Birth
Interventions: Low-Dose Aspirin Dose: 81 mg & Lansoprazole Dose: 30 mg, Standard of Care; Drug · Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 670 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2032
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Obstructive Sleep Apnea
Interventions: Autoadjusting CPAP (VPAP Auto), CPAP; Device
Lead sponsor: MetroHealth Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Mild Cognitive Impairment
Interventions: PRISEM Remote; Behavioral
Lead sponsor: Emory University; Other
Eligibility: 50 Years and older
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 2
States / cities: Atlanta, Georgia

Conditions: Post Traumatic Stress Disorder
Interventions: Service Dog Training Program, Dog Training Education; Behavioral · Other
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Boyds, Maryland

Conditions: Obesity, Childhood, Weight Change, Body, Quality of Life
Interventions: Kids N Fitness Program; Behavioral
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: 6 Years to 14 Years
Enrollment: 27 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Surgery
Interventions: Routine Elective Surgery- In patient or out patient elective surgery, Blood test for genetic testing, Drug-genetic Profile; Procedure · Diagnostic Test · Other
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years and older
Enrollment: 1,900 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Alzheimer's Disease
Interventions: F-18 FDG, C-11 PiB; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 30 Years to 49 Years
Enrollment: 41 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Peripheral Neuropathy
Interventions: Alpha lipoic acid; Drug
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: HIV-1 Infection, Hepatitis
Interventions: Sofosbuvir, Ribavirin, Ledipasvir/Sofosbuvir; Drug
Lead sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections; Network
Eligibility: 18 Years and older
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 12
States / cities: San Diego, California • San Francisco, California • Washington D.C., District of Columbia + 7 more

Conditions: Brain Neoplasms
Interventions: Tumor fluorescence; Drug
Lead sponsor: Southern Illinois University; Other
Eligibility: 18 Years and older
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2021
U.S. locations: 1
States / cities: Springfield, Illinois

Conditions: Generalized Anxiety Disorder
Interventions: PF-06372865.; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 47
States / cities: Cerritos, California • Encino, California • Imperial, California + 41 more

Conditions: Overweight, Obesity
Interventions: Lookin' Good Feelin' Good, Information attention-control; Behavioral
Lead sponsor: University of Massachusetts, Worcester; Other
Eligibility: 13 Years to 18 Years
Enrollment: 126 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Worcester, Massachusetts

Conditions: Appendicitis, Child, Contrast Media
Interventions: CT Scan using IV contrast alone; Other
Lead sponsor: University of Rochester; Other
Eligibility: 3 Years to 18 Years
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2005
U.S. locations: 1
States / cities: Rochester, New York

Conditions: ASCVD Management
Interventions: Pharmacy Intern Counseling; Behavioral
Lead sponsor: University of Texas at Austin; Other
Eligibility: 18 Years and older
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Medication Adherence, HIV Prevention, Stimulant Use
Interventions: PARTI, Attention-Control, Contingency Management for PrEP Adherence; Behavioral
Lead sponsor: Florida International University; Other
Eligibility: 18 Years and older · Male only
Enrollment: 239 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2026
U.S. locations: 2
States / cities: San Francisco, California • Miami, Florida

Conditions: Hepatocellular Carcinoma
Interventions: SD-101, Cryotherapy, Tremelimumab, Durvalumab; Drug · Device
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: San Diego, California

Conditions: Acute Stroke, Ischemic Stroke, Stroke
Interventions: Recombinant human tissue kallikrein, Placebo for DM199 Solution for Injection; Drug · Other
Lead sponsor: DiaMedica Therapeutics Inc; Industry
Eligibility: 18 Years to 90 Years
Enrollment: 728 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 36
States / cities: Fairhope, Alabama • Arcadia, California • Glendale, California + 29 more

Conditions: Urinary Incontinence, Pelvic Organ Prolapse
Interventions: Standardized visual presentation; Other
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 64 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2018
U.S. locations: 1
States / cities: Boston, Massachusetts

Search by objective public record fields.

Auriculo-Nerve Stimulation on Post-Operative Opioid Requirement

Study of the Effects of Brilacidin Oral Rinse on Radiation-induced Oral Mucositis in Patients With Head and Neck Cancer

A Qualitative Case Study of the Experiences of Children With Cancer as They Learn About Their Diagnosis and Treatment

Nurse Managed Sequential Strength Training and Bicycle Training in Chronic Obstructive Pulmonary Disease (COPD)

A Stepped-Wedge Cluster Randomized Trial of a Digital App to Support Medication-Assisted Treatment in Individuals With Opioid Use Disorder

Safety and Therapeutic Drug Monitoring of Cefazolin in Continuous Renal Replacement Therapy

Efficacy and Safety of Aspirin and Lansoprazole for Prevention of Preterm Birth in High-Risk Pregnant Women: A Biomarker-Enriched Trial

CPAP vs AutoCPAP for Treatment of Obstructive Sleep Apnea (OSA) in the Postoperative Setting

PRogram to Improve Stress-levels and Enhance Memory

Service Dog Training Program for Military Veterans With PTSD

Feasibility of the Camp Power Up Program on Children's Body Weight and Quality of Life

The ImPreSS Trial: Pharmacogenomic Decision Making at Time of Surgery

Normative Values for Cognitive Testing and Alzheimer's Imaging Biomarkers in Young Adults

Alpha-lipoic Acid in Patients at Risk for Paclitaxel Induced Neuropathy

Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection

A Study of the Specificity and Sensitivity of 5- Aminolevulinic Acid (ALA) Fluorescence in Malignant Brain Tumors

POC Study in Partially Responsive Generalized Anxiety Disorder

School Nurse Intervention and After School Exercise Program for Overweight Teens

CT Scan Using IV Contrast Alone for Pediatric Appendicitis

Optimizing Non-statin Agents for ASCVD

PrEP Affect Regulation Treatment Innovation

Cryoablation and Arterial Infusion of SD-101 in Combination With Durvalumab and Tremelimumab

Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)

Effect of Standardized Consent for Urogynecological Procedures on Patient Satisfaction